Precision BioSciences Inc. (NASDAQ: DTIL)
$7.2700
+0.0100 ( +0.14% ) N/A
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$7.2700
Previous close
$7.2600
Volume
N/A
Market cap
$55.69M
Day range
$7.2600 - $7.2600
52 week range
$6.4100 - $19.4299
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
def | Proxies and info statements | 3 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |